H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

H.I.G. Capital has completed the acquisition of the Spine division of ZimVie, which has been renamed Highridge Medical and will operate as an independent entity.

Headquartered in Westminster, CO, Highridge is a leader in the global spinal device market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies, with a market-leading portfolio of bone healing therapies.

Highridge has a robust foundation of spine solutions supported by extensive clinical evidence and patient outcomes to build upon. We believe our partnership with H.I.G. Capital to create the largest privately held spine business in the industry will generate lasting benefits for distributors, surgeons, and patients,” said Glen Kashuba, who will join Highridge as the Chief Executive Officer.

The current management team has made significant progress across the organization, and we believe this partnership will solidify Highridge’s market-leading position and will deliver increased value to the surgeons and patients we serve,” said Rebecca Whitney, President of Highridge.

H.I.G. has followed the spine market closely for many years, and we believe Highridge is uniquely positioned to succeed in this market. We are looking forward to significant growth through operational excellence, increased investment into our R&D pipeline, and strategic acquisition opportunities,” said Gwen Watanabe, Managing Director at H.I.G. Capital, a leading global alternative investment firm with $60 billion of capital under management. Since its founding in 1993, H.I.G. Capital has invested in and managed more than 400 companies worldwide including Augmedics, Vertiflex (acquired by Boston Scientific), Neuwave Medical (acquired by J&J), and Intact Vascular (acquired by Philips).

To view the source version, please click HERE.

en_GBEnglish (UK)